| 2014 | | Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus. | 김현아, 서창희, 전자영, 정주양 |
| 2012 | | C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin | 김현아, 서창희, 전자영 |
| 2021 | | Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis | 김현아 |
| 2016 | | Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash | 김현아, 서창희, 손성향, 정주양 |
| 2016 | | Hyponatremia in patients with systemic lupus erythematosus | 박세진, 서창희 |
| 2005 | | Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. | 남동호, 박해심, 서창희, 조재현 |
| 2015 | | Role of bone scan in the assessment of polymyositis/dermatomyositis. | 김현아, 서창희, 안영실, 정주양 |
| 2017 | | Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2014 | | Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. | 김현아, 서창희, 전자영, 정주양 |
| 2012 | | Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease | 김현아, 서창희, 전자영 |
| 2017 | | Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry | 김현아 |
| 2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2016 | | TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations | 김유선, 김현아, 서창희, 임현이, 정주양, 한재호 |
